Sirtratumab vedotin (ASG15-ME) is an antibody-drug conjugate (ADC) that links a SLITRK6-specific human gamma 2 antibody (Iggamma2) to the microtubule disruption agent monomethyl auristatin E (MMAE) through a protease-cleavable linker [1].
CAS Number:
[1824663-83-3]
Target:
Others|||Antibody-Drug Conjugates (ADCs)
* VAT and and shipping costs not included. Errors and price changes excepted